Medical cannabis in the UK and the industry’s future
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments.
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as legalization of medical and recreational cannabis. In this context, patients and their physicians have had an increasing number of conversations about the risks and benefits of cannabis.
Barney’s Farm’s exquisite Cali collection presently encompasses 13 strains, and the almost pure indica (80%) Shiskaberry is one of them.
Growing up as a child I was always a rebel, so I started smoking at a young age.
If you’ve been a reader of Weed World for a while, you’re likely to remember the story of Billy Caldwell and his mother, Charlotte.
The ever-evolving situation revolving around legislation and guidelines for medicinal cannabis patients in the UK shows no signs of becoming less complicated, confusing or convoluted, but there is certainly at least a glimmer of hope for the future if reports in the past month are anything to go by.
Minnesota’s medical cannabis program is unique, in that it routinely collects patient-reported scores on symptoms. This article focuses on changes in symptom severity reported by patients with cancer during their first 4 months of program participation.
The use of cannabis for medical purposes has been recently legalised in many countries including the Czech Republic.